doi: 10.1186/s10194-024-01805-3
FDA Warning: RISK FOR ILEUS (INTESTINAL BLOCKAGE) (FDA 09/22/2023) Amongst more than 8,500 voluntary reports of GI disorders associated with the use of semaglutide reported through June 30, 2023, ileus was included in 33 cases, and two cases of death
Some plans distinguish between diabetes indication (typically covered) and weight management alone (frequently denied or limited to a set number of months per year)
Getting the most out of GLP-1 therapy means staying on top of your injections, hitting your protein targets despite a suppressed appetite, maintaining muscle through resistance training, and managing the mental load that comes with a significant lifestyle change
Some users split their weekly retatrutide dose into smaller, more frequent injections to reduce peak-related side effects and maintain more stable drug levels